AFELTRA, Antonella Maria Vittoria
 Distribuzione geografica
Continente #
AS - Asia 942
NA - Nord America 583
EU - Europa 380
OC - Oceania 8
SA - Sud America 4
AF - Africa 3
Totale 1.920
Nazione #
SG - Singapore 687
US - Stati Uniti d'America 566
CN - Cina 135
IT - Italia 128
GB - Regno Unito 123
HK - Hong Kong 79
NL - Olanda 36
DE - Germania 31
FI - Finlandia 22
TR - Turchia 18
CA - Canada 13
IN - India 13
CZ - Repubblica Ceca 10
FR - Francia 10
AU - Australia 8
UA - Ucraina 5
AT - Austria 3
MX - Messico 3
BR - Brasile 2
ES - Italia 2
HU - Ungheria 2
ID - Indonesia 2
JP - Giappone 2
RU - Federazione Russa 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
ET - Etiopia 1
JO - Giordania 1
KH - Cambogia 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
RS - Serbia 1
SA - Arabia Saudita 1
SE - Svezia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 1.920
Città #
Singapore 197
Ashburn 143
London 118
Boardman 115
Hong Kong 76
Shanghai 71
Council Bluffs 53
West Jordan 40
Rome 33
Amsterdam 29
Los Angeles 23
Helsinki 22
Sona 20
Seattle 18
San Francisco 17
Washington 17
Bari 15
Munich 15
Santa Clara 12
Ankara 11
Pune 11
Toronto 11
Brno 10
Changsha 7
Chengdu 4
Duino-Aurisina 4
Haikou 4
Milan 4
Naples 4
Noicattaro 4
State College 4
Beijing 3
Paris 3
Redmond 3
Sydney 3
Brest 2
Canberra 2
Central 2
Cuernavaca 2
Guiyang 2
Handan 2
Herne Bay 2
Ho Chi Minh City 2
Linyi 2
Melbourne 2
Messina 2
Perugia 2
Reus 2
Rockville 2
Tianjin 2
Tokyo 2
Vienna 2
Ajman 1
Almere Stad 1
Amman 1
Belgrade 1
Bologna 1
Borås 1
Bourne 1
Budapest 1
Charlotte 1
Chicago 1
Clifton 1
Cold Lake 1
Columbia 1
Delhi 1
Dongguan 1
Foggia 1
Foligno 1
Guangzhou 1
Hefei 1
Houston 1
Jiangmen 1
Jianning 1
Jiaxing 1
Krasnoyarsk 1
Lima 1
Lincoln 1
Luoyang 1
Lüleburgaz 1
Markham 1
Mexico City 1
Newark 1
Pasadena 1
Phnom Penh 1
Pontonx-sur-l'Adour 1
Riyadh 1
Sarajevo 1
Sassano 1
Secaucus 1
Serdivan 1
Siena 1
São Paulo 1
Taiyuan 1
Tallinn 1
Tangshan 1
Tunis 1
Vyzhnytsya 1
Warsaw 1
Wuhan 1
Totale 1.206
Nome #
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 54
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 39
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 35
Enhanced portal flow velocity and volume following Iloprost treatment 34
GH-resistance in different stages of chronic liver disease 33
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 31
Diabetes in chronic liver disease: from old concepts to new evidence 31
Automatic acquisition of Immunofluorescence images: algorithms and evaluation 30
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 29
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 29
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 29
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 28
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 28
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 27
TNF-alpha and growth hormone resistance in patients with chronic liver disease 27
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 27
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 27
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 26
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 26
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 25
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 25
Radiofrequency ablation of hepatic tissue: a new experimental animal model 25
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 25
Leptin in immuno-rheumatological diseases 24
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 24
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 24
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 23
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 22
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 22
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 21
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 21
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 21
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 21
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox 21
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 21
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 20
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 20
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 20
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 20
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 20
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 20
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 19
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system 19
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 19
ANA testing in ‘real life’ 19
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 19
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 18
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 18
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 18
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 18
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 18
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 18
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 18
Matters of the heart: The case of TNF-alpha targeting drugs 18
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 18
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 18
Cannabinoids in Autoimmune and Rheumatic Diseases 17
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 17
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 17
Leptin in autoimmune mechanisms of systemic rheumatic diseases 17
Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis 16
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 16
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 16
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 16
Surgical complications after resection of adrenal carcinoma 16
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk 16
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 15
Serum level of endostatin and digital ulcers in systemic sclerosis patients 15
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 15
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 15
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 15
Indirect immunofluorescence in autoimmune diseases: assessment of digital images for diagnostic purpose 15
Pain and Frailty in Hospitalized Older Adults 15
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 15
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 14
Utility of ultrasound in the diagnosis of chronic worsened gout 14
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 14
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 14
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 14
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 14
Intrarenal arterial stiffness is increased in systemic sclerosis patients with anti-ribonucleic acid polymerase III antibodies 13
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 13
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 13
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 13
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 13
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 12
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 12
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 12
In systemic sclerosis, microvascular and hands digital arteries damage correlates with serum levels of endostatin 12
Tumour necrosis factor alpha (TNFα)cardiomyocyte preconditioning: clues to explain anti-TNFα agents contraindication in severe heart failure 12
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 12
Tnf-alpha induced cardioprotection: effects on reactive oxygen species (ros) and apoptosis 12
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis 12
Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis 11
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 11
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 11
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 11
Strain Ultrasound Elastography in the Achilles Tendon of Ankylosing Spondylitis Patients Treated With Anti-TNF-α: A Preliminary Study. 10
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 10
The inter-observer reading variability in anti-nuclear antibodies indirect (ANA) immunofluorescence test: A multicenter evaluation and a review of the literature 10
Totale 1.953
Categoria #
all - tutte 30.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.215


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022133 0 1 0 0 1 2 2 6 14 4 2 101
2022/2023137 19 0 0 2 38 2 8 7 2 3 55 1
2023/2024439 26 39 20 37 34 167 5 25 5 48 12 21
2024/20251.277 58 41 143 42 94 123 40 25 265 355 91 0
Totale 1.986